Demet Kartal

Prof. Dr. Demet Kartal


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
DKDemet Kartal
Demet Kartal
MBMurat Borlu
Murat Borlu
SÇSalih Levent Çınar
Salih Levent Çınar
AKAyten Kesikoğlu
Ayten Kesikoğlu
SUSerap Utaş
Serap Utaş
Introduction : The association between vitiligo and thyroid disease is not fully investigated especially in paediatric patients. Aim : To determine the incidence of vitiligo and thyroid disorders in children. This is the first report from middle Anatolia and the second report from Turkey....

15 September 2015
Verified
Journal Article
Closed access
DKDemet Kartal
Demet Kartal
HYH Yıldız
H Yıldız
RER Ertaş
R Ertaş
MBmurat borlu
murat borlu
SUS Utaş
S Utaş

1 March 2017 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
DKDemet Kartal
Demet Kartal
MYMehmet Yaşar
Mehmet Yaşar
LKLevent Kartal
Levent Kartal
IÖIbrahim Özcan
Ibrahim Özcan
MBMurat Borlu
Murat Borlu
Keywords: Isotretinoin; Olfaction disorders; Smell

10 April 2015 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
DKDemet Kartal
Demet Kartal
MBM. Borlu
M. Borlu
CHCristina Has
Cristina Has
RFR. Fölster‐Holst
R. Fölster‐Holst

17 March 2015 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
DKDemet Kartal
Demet Kartal
MBmurat borlu
murat borlu
SÇSalih L Çınar
Salih L Çınar
AFAyten Ferahbaş
Ayten Ferahbaş
YUYılmaz Ulaş
Yılmaz Ulaş
FKFahrettin Keleştimur
Fahrettin Keleştimur

28 September 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
DKDemet Kartal
Demet Kartal
SOShahzada Orujova
Shahzada Orujova
RERagıp Ertaş
Ragıp Ertaş
Background: The relationship between CSU and vaccines is reported in the literature. The post-vaccine clinical effect of COVİD-19 vaccines on CSU patients is still unclear. we aimed to evaluate clinical effects of COVID-19 Vaccines on CSU patients.Materials and methods: CSU patients under treatment and follow-up in our outpatient clinic were evaluated retrospectively. To determine disease activity the urticaria activity score over seven days (UAS7) was used. The details of demographic information, CSU treatment, history of COVID-19 infection and exacerbation of urticaria during infection, COVID-19 vaccinations, type of vaccine, side effect reaction time after vaccination, hospital admission requirement were also assessed.Results: Total of 190 patients with a mean age of The mean age of patients was 41,7±14,0 years (range = 18–72) were enrooled. The patient sample consisted of 50 males and 140 females (male/female ratio 1:2.8). 181 (CoronaVac 77, Pfizer-BioNTech 104) patients were vaccinated. Urticarial exacerbation was occurred in 25 patients. The median UAS value was 5 before vaccination, it was 12 in patients with post-vaccine urticaria. Two patients had angioedema and one patient had anaphylaxis after vaccinated with Pfizer-BioNTech.Conclusion: COVID-19 vaccination in the CSU can be considered safe. Cases with urticarial exacerbation appear to be transient and can be managed by antihistamine and/or systemic steroid therapies. More extensive studies are needed for the relationship with CSU and post-coronavirus vaccination anaphylaxy.